ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Nuvectis Pharma Inc

Nuvectis Pharma Inc (NVCT)

6.94
0.32
(4.83%)
Closed July 26 4:00PM
6.94
0.00
(0.00%)
After Hours: 6:41PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
6.94
Bid
6.56
Ask
7.20
Volume
20,102
6.53 Day's Range 6.95
5.85 52 Week Range 15.50
Market Cap
Previous Close
6.62
Open
6.63
Last Trade
191
@
6.94
Last Trade Time
Financial Volume
$ 135,569
VWAP
6.7441
Average Volume (3m)
97,652
Shares Outstanding
18,356,060
Dividend Yield
-
PE Ratio
-5.72
Earnings Per Share (EPS)
-1.21
Revenue
-
Net Profit
-22.26M

About Nuvectis Pharma Inc

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $6.62. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 5.85 to $ 15.50.

Nuvectis Pharma currently has 18,356,060 shares outstanding. The market capitalization of Nuvectis Pharma is $121.52 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -5.72.

NVCT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.416.27871362946.537.06316.4575262976.74883681CS
40.6610.50955414016.287.06316991496.40278743CS
120.010.14430014436.938.455.85976526.58171355CS
26-0.69-9.043250327657.6312.15.85952957.5496063CS
52-7.52-52.005532503514.4615.55.85747768.57164575CS
1562.9975.69620253163.9520.923.081983187.95573781CS
2602.9975.69620253163.9520.923.081983187.95573781CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.45M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

NVCT Discussion

View Posts
Monksdream Monksdream 3 weeks ago
NVCT under $10
👍️0
Monksdream Monksdream 3 months ago
NVCT under $10
👍️0
Monksdream Monksdream 5 months ago
NVCT 10Q due March 6
👍️0
Monksdream Monksdream 7 months ago
NVCT a bounce
👍️0
conix conix 2 years ago
NVCT HIGHLIGHTS:

*Recently completed Initial Public Offering - $5.00 Per share
*2 Precision Cancer medicines in development - ovarian and triple negative breast
*Data flow throughout 2022
*CEO with multiple success stories in life science sector to $billion dollar market caps
*Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

Nuvectis Pharma Inc - Company Background:

Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

Market Capitalization: $225 million
Range - 52 week: $3.08 - $20.75
Current Price: $20.44
Trades on: Nasdaq Capital Market
Ticker Symbol: NVCT

website: nuvectis.com
👍️0
TheFinalCD TheFinalCD 2 years ago
wow from $3 to almost $21
👍️0
ipo_dude ipo_dude 2 years ago
$27 we come
👍️0
TheFinalCD TheFinalCD 2 years ago
WOW $7 MOVE 3-10


CONGRAT$ NVCT
👍️0
spindog spindog 2 years ago
I feel the same
👍️0
kkballa kkballa 2 years ago
hmmm.
👍️0